Spectrum appoints Dr Dalna Harvey as regulatory project manager
pharmafile | April 8, 2014 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Spectrum, Wyeth, woodley
Spectrum Regulatory Solutions, a company that provides a consultancy to the healthcare industry, has added to its regulatory team by appointing Dr Dalna Harvey as its new regulatory project manager.
Dr Harvey has a wealth of experience in regulatory affairs, working for companies such as Parexel, Chiron Corporation, Wyeth (now a part of Pfizer), Pliva London and, most recently, Woodley BioReg.
She will be responsible for updating Spectrum’s global healthcare clients on legislation amendments, providing strategic and technical advice and maintaining marketing authorisations.
“I am excited to join Spectrum and to develop its regulatory affairs service offering”, says Harvey.
Dr Angela Gisby, managing director of Spectrum, adds: “We are pleased to welcome Dalna to Spectrum and we look forward to the expert contribution she will bring to the business, particularly in the area of regulatory intelligence.”
Related Content

Medicinal cannabis company Spectrum makes first shipment into UK
Medicinal cannabis company Spectrum Europe has made its first shipment of cannabis into the UK, …

Pfizer to pay $784.6 million fine due to Wyeth Medicaid fraud
Pfizer has agreed to pay $784.6 million in a settlement with the US Department of …
Pfizer pays $784m to settle Protonix overcharge claims
US drugs giant Pfizer is to pay more than $784 million to settle claims that …






